BioTech Mag Search: Therapeutics
Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas
A preclinical central nervous system biotech is in the works in La Jolla, CA, and the drug developer has reeled in capital from a syndicate of investors, Endpoints News has...
52 minutes ago - San Diego Biotechnology
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
LA JOLLA, Calif.--- $EQ-Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders...
3 hours ago - San Diego Biotechnology
A new Vega enters the galaxy with bleeding disorder antibody set for 2023 trial
Biotech incubator Star Therapeutics has launched another galaxy-themed drug developer, which next year will test a new antibody in a bleeding disorder currently treated by...
3 hours ago - San Diego Biotechnology
Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH
SAN DIEGO--Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas...
3 hours ago - San Diego Biotechnology
TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
Abstract Background The tripartite motif family of proteins plays a key role in the developmental growth and therapeutic resistance of many tumors. However, the regulatory...
10 hours ago - Springer
Visualizing extracellular vesicle biogenesis in gram-positive bacteria using super-resolution microscopy
Abstract Background Recently, bacterial extracellular vesicles have been considered to play crucial roles in various biological processes and have great potential for...
1 day ago - Springer
CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction
Abstract Background Since angiogenesis occurs as the pathological process following myocardial infarction to alleviate ischemia, therapeutic angiogenesis has been proposed to...
2 days ago - Springer
Research Associate I/II - Belharra Therapeutics, Inc. - San Diego, CA
Belharra is seeking a highly engaged, inquisitive, detail oriented, and creative research associate with diverse expertise in quantitative mass spectrometry,...From Belharra...
2 days ago - San Diego Biotechnology
Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma
Abstract Multiple myeloma remains an incurable disease and there is an unmet medical need for novel therapeutic drugs that do not share similar mechanisms of action with...
3 days ago - Springer
Micronome Revealed miR-205-5p as Key Regulator of VEGFA During Cancer Related Angiogenesis in Hepatocellular Carcinoma
Abstract The high ratio of global mortality rate to incidence rate and steep increase in incidence of liver cancer warrants need for advancement of innovative cancer treatment...
3 days ago - Springer
Free Registration
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas
A preclinical central nervous system biotech is in the works in La Jolla, CA, and the drug developer has reeled in capital from a syndicate of investors, Endpoints News has...
Calidi Biotherapeutics to Present at the 7th Annual Oncolytic Virotherapy Summit
LA JOLLA, Calif.--Calidi Biotherapeutics to Present at the 7th Annual Oncolytic Virotherapy Summit
Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
CARLSBAD, Calif.--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TrueMark Infectious Disease Research Panels designed to...
Rescue of an enterotropic Newcastle disease virus strain ZM10 from cloned...
Newcastle disease virus strain ZM10, a typical enterotropic avirulent vaccine strain, has been widely used in China for chickens against Newcastle disease. To elucidate its...
Extended-release of doxorubicin through green surface modification of gold...
In the present study, a green surface modification of gold nanoparticles using chondroitin sulfate and chitosan to deliver an extended-release of doxorubicin was proposed...
Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY...
SAN DIEGO--Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas...
A new Vega enters the galaxy with bleeding disorder antibody set for 2023 trial
Biotech incubator Star Therapeutics has launched another galaxy-themed drug developer, which next year will test a new antibody in a bleeding disorder currently treated by...
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset...
LA JOLLA, Calif.--- $EQ-Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders...
Scientist-Immuno-Oncology Flow Cytometry - Novartis - Carlsbad, CA
Navigate Biopharma, a fully owned subsidiary of Novartis, provides assay development, clinical trial testing, and companion diagnostics services to companies...
As FDA door shuts on its PI3K, MEI Pharma throws in the towel, lays off staff
Having steered a PI3K inhibitor from preclinical studies all the way to Phase II, San Diego's MEI Pharma is all but washing its hands of the drug as the FDA raises the bar on...